U.S. Markets close in 20 mins

Tetraphase Slumps: TTPH Falls 10.3% in Session

Zacks Equity Research

Tetraphase Pharmaceuticals, Inc. (TTPH) saw a big move last session, as the company’s shares fell by over 10% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the most recent downtrend for TTPH as the stock is now down over 22% since April 2.

The biopharmaceutical company has seen a mixed track record when it comes to current year estimate revisions over the past few weeks. However, the current year consensus for loss has widened over the last 30 days. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

Tetraphase currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.0%.

Some better-ranked stocks in the same sector include Shire (SHPG), Astellas Pharma, Inc. (ALPMY) and IntelliPharmaCeutics International Inc. (IPCI). All these stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


SHIRE PLC ADS (SHPG): Free Stock Analysis Report

ASTELLAS PHARMA INC (ALPMY): Free Stock Analysis Report

(IPCI): Free Stock Analysis Report

Zacks Investment Research